LME636
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for LME636, covering 2017-08-28 to 2017-11-24. Get the full timeline:
Most recent: Clinical Trial Update: LME636 in the Relief of Persistent Ocular Discomfort in Subjects With Severe Dry Eye Disease [Phase 2]